NetworkNewsBreaks

FridayAug 13, 2021 12:44 pm

NetworkNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Highlights Milestones of First Year Under Former ‘Big Tobacco’ Executive Leadership

TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) today provided a “year in review” summary of the company’s performance and accomplishments since August 2020 when it added two former “Big Tobacco” players to its executive team. These include Chief Executive Officer Setti Coscarella (former lead strategist for Philip Morris International) and Chief Revenue Officer Tim Corkum (former international commercialization executive for Philip Morris International). Under the leadership of Coscarella and Corkum, the company has completed development of TAAT(TM) and has successfully launched the product at retail in multiple U.S. states with a total store count of more than 500, in addition…

Continue Reading

FridayAug 13, 2021 11:56 am

NetworkNewsBreaks – Microdose Psychedelic Insights to Deep Dive into World of Psychedelic Medicine Investment at Upcoming Conference

Microdose Psychedelic Insights, a cutting-edge media company aiming to move the psychedelics industry to the forefront of modern medicine, today announced that it will host the upcoming Psychedelic Capital conference. The virtual event is slated to take place on August 31, 2021, and provide attendees with access to the top companies, latest IPOs, newest opportunities, and deepest industry insights in the growing psychedelic medicine sector. As part of a series of conferences diving deep into the world of psychedelic medicine investment, the event seeks to introduce investors and attendees to a curated group of CEOs, capital advisors and investment luminaries…

Continue Reading

FridayAug 13, 2021 11:46 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Schedules Conference Call to Discuss Q1 2022 Earnings

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), has announced an upcoming teleconference to discuss its financial report for the first quarter ended June 30, 2021. The call is scheduled for Monday, Aug. 16, 2021, at 55 p.m. ET. Richard Wright, WTER president and CEO, and David Guarino, WTER chief financial officer, will host the call. Investors, analysts and other interested parties are invited to participate. U.S. and Canadian callers should dial 877-407-3088; international callers should dial 201-389-0927. All callers will need to use conference ID number 13722270. A…

Continue Reading

FridayAug 13, 2021 10:58 am

NetworkNewsBreaks – DSG Global Inc.’s (DSGT) Imperium Motors to Showcase Latest EV Technologies at Upcoming Montreal and Quebec Electric Vehicle Shows

DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in rapidly growing market sectors, today announced that Imperium Motors Canada will attend the Montreal Electric Vehicle Show in September and the Quebec Electric Vehicle Show in early October as demand for its electric vehicles (“EVs”) continues to escalate. According to the update, the Montreal Electric Vehicle Show is the largest EV gathering in Canada and runs from September 17-19, 2021, at the Olympic Stadium. The Quebec Electric Vehicle Show, to be held at the Centre de foires de Québec from October 1-3, 2021, attracts…

Continue Reading

FridayAug 13, 2021 10:14 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2021 Financial Results, Provides Business Outlook

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today reported its financial results for the quarter ended June 30, 2021. The company also provided a clinical update of its anti-cancer drug candidates currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of the second quarter, our team continued to execute on corporate, clinical and regulatory strategies to drive our Berubicin program toward regulatory approval as fast as possible. We are guided by our…

Continue Reading

FridayAug 13, 2021 9:48 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Sees More than $1M in Orders in First Month

Pressure BioSciences (OTCQB: PBIO) announced that PBI Agrochem Inc., its new subsidiary, has received purchase orders totaling more than $1 million in its first month of operation. Agrochem provides ecofriendly agrochemical products, and the orders are for products to be delivered before year end. PBIO, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, formed the new subsidiary in anticipation of the acquisition of a global agrochemicals products business focused on organically natural and environmentally responsible products. PBI's Ultra…

Continue Reading

FridayAug 13, 2021 9:38 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q2 2021 Financial, Operational Report

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has announced its most recent financial report, along with operational highlights for the second quarter, the period ended June 20, 2021. In part, the report noted that second-quarter revenue totaled $4.5 million, an increase of more than 37% year over year, and 30% over the first quarter 2021; revenue for the first half of 2021 totaled $7.9 million. Gross profit for second quarter was $3.6 million with gross margin 81%…

Continue Reading

FridayAug 13, 2021 9:38 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Q1 Milestones for Subsidiary — Notes Corrected Information

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has noted key achievements reached by its wholly owned subsidiary Adelia Therapeutics Inc. Most notably, Adelia has achieved key milestones outlined in the terms of a contribution agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and previous Adelia shareholders. Those milestones are for Year 1 Q3 (i)-(iii) and Year 1 Q4 (i) and (iii), as contemplated by the terms of the Dec. 7, 2020, agreement. Consequently, the company announced that, in accordance with the agreement, Class B common shares will be issued to Adelia shareholders…

Continue Reading

ThursdayAug 12, 2021 3:17 pm

NetworkNewsBreaks – Myomo, Inc. (NYSE American: MYO) Featured in Earnings Release Note from Sidoti

2Q:22 Results Exceed Our Estimates As Revenue Triples Myomo (NYSE American: MYO) was featured in a company-sponsored research earnings release note published by Sidoti & Company, LLC. The report reads, “There are now more 898 units waiting for reimbursement approval, compared to 768 units at the end of 2020… We expect order rates in the United States to accelerate as reimbursement improves.” To access the full report, visit https://nnw.fm/Mehww About Myomo, Inc. Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro…

Continue Reading

ThursdayAug 12, 2021 3:07 pm

NetworkNewsBreaks – LGL Group, Inc. (NYSE American: LGL) Featured in Earnings Preview Research at Sidoti

Expect 1Q:21 Was A Trough Quarter; Project A 15% Sequential 2Q:21 Revenue Increase; LGL Group (NYSE American: LGL) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “We think LGL provides an exciting investment opportunity as it potentially could provide outsized upside compared to the risk via its SPAC investment.  The company exited 2Q:21 with no debt and $25 million in cash, representing 50% of its market cap, which we think positions it well for further accretive M&A activity.” To access the full report, visit https://nnw.fm/d0pZa About LGL Group, Inc. The…

Continue Reading